Androgen receptor signaling affects response to targeted therapy in people with melanoma - News-Medical.Net

6/15/2022 12:00:00 AM2 years 10 months ago

Androgen receptor (AR) signaling affects response to BRAF/MEK inhibitor therapy in both males and females with melanoma, researchers from The University of Texas MD Anderson Cancer Center showed in a study published today in Nature.

Androgen receptor (AR) signaling affects response to BRAF/MEK inhibitor therapy in both males and females with melanoma, researchers from The University of Texas MD Anderson Cancer Center showed in a… [+5676 chars]

full article...